A detailed history of Russell Investments Group, Ltd. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 9,529 shares of BIO stock, worth $3.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,529
Previous 6,504 46.51%
Holding current value
$3.34 Million
Previous $1.78 Million 79.5%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$263.97 - $344.64 $798,509 - $1.04 Million
3,025 Added 46.51%
9,529 $3.19 Million
Q2 2024

Aug 08, 2024

SELL
$268.26 - $339.48 $52,578 - $66,538
-196 Reduced 2.93%
6,504 $1.78 Million
Q1 2024

May 08, 2024

SELL
$304.11 - $351.99 $2.58 Million - $2.99 Million
-8,499 Reduced 55.92%
6,700 $2.32 Million
Q4 2023

Feb 05, 2024

SELL
$269.37 - $365.04 $2.3 Million - $3.12 Million
-8,546 Reduced 35.99%
15,199 $4.91 Million
Q3 2023

Nov 13, 2023

BUY
$350.25 - $422.63 $928,162 - $1.12 Million
2,650 Added 12.56%
23,745 $8.51 Million
Q2 2023

Aug 10, 2023

SELL
$359.49 - $486.4 $10.3 Million - $14 Million
-28,770 Reduced 57.7%
21,095 $8 Million
Q1 2023

May 09, 2023

SELL
$418.69 - $503.0 $4.4 Million - $5.28 Million
-10,500 Reduced 17.39%
49,865 $23.9 Million
Q4 2022

Feb 08, 2023

SELL
$351.71 - $456.01 $2.66 Million - $3.45 Million
-7,564 Reduced 11.14%
60,365 $25.4 Million
Q3 2022

Nov 04, 2022

BUY
$412.59 - $563.26 $186,078 - $254,030
451 Added 0.67%
67,929 $28.4 Million
Q2 2022

Jul 29, 2022

SELL
$463.67 - $597.16 $14.8 Million - $19.1 Million
-32,015 Reduced 32.18%
67,478 $33.4 Million
Q1 2022

May 05, 2022

SELL
$524.57 - $735.42 $11 Million - $15.4 Million
-20,960 Reduced 17.4%
99,493 $56.8 Million
Q4 2021

Jan 21, 2022

BUY
$708.84 - $794.68 $185,007 - $207,411
261 Added 0.22%
120,453 $91.1 Million
Q3 2021

Nov 08, 2021

BUY
$657.71 - $825.77 $10.4 Million - $13.1 Million
15,833 Added 15.17%
120,192 $89.8 Million
Q2 2021

Aug 04, 2021

BUY
$576.64 - $649.04 $12.7 Million - $14.3 Million
22,013 Added 26.73%
104,359 $67.3 Million
Q1 2021

May 10, 2021

BUY
$547.01 - $662.35 $13.4 Million - $16.2 Million
24,425 Added 42.17%
82,346 $46.8 Million
Q4 2020

Feb 08, 2021

SELL
$510.68 - $643.45 $1.63 Million - $2.06 Million
-3,194 Reduced 5.23%
57,921 $33.6 Million
Q3 2020

Nov 09, 2020

SELL
$454.43 - $535.6 $1.43 Million - $1.69 Million
-3,148 Reduced 4.9%
61,115 $31.5 Million
Q2 2020

Aug 05, 2020

SELL
$334.87 - $493.06 $9.06 Million - $13.3 Million
-27,041 Reduced 29.62%
64,263 $28.5 Million
Q1 2020

May 06, 2020

SELL
$320.01 - $409.07 $10.4 Million - $13.2 Million
-32,386 Reduced 26.18%
91,304 $32 Million
Q4 2019

Jan 29, 2020

SELL
$319.73 - $374.2 $32.1 Million - $37.6 Million
-100,384 Reduced 44.8%
123,690 $45.8 Million
Q3 2019

Nov 01, 2019

SELL
$304.55 - $345.24 $57 Million - $64.6 Million
-187,188 Reduced 45.52%
224,074 $74.6 Million
Q2 2019

Aug 09, 2019

BUY
$286.93 - $312.59 $4.44 Million - $4.84 Million
15,486 Added 3.91%
411,262 $128 Million
Q1 2019

May 13, 2019

BUY
$224.3 - $317.41 $16.7 Million - $23.7 Million
74,663 Added 23.25%
395,776 $121 Million
Q4 2018

Feb 11, 2019

BUY
$220.1 - $309.0 $43 Million - $60.4 Million
195,446 Added 155.53%
321,113 $74.4 Million
Q3 2018

Oct 26, 2018

BUY
$289.28 - $326.15 $9.85 Million - $11.1 Million
34,042 Added 37.15%
125,667 $39.3 Million
Q2 2018

Aug 08, 2018

SELL
$244.1 - $303.88 $6.12 Million - $7.61 Million
-25,054 Reduced 21.47%
91,625 $26.4 Million
Q1 2018

May 11, 2018

BUY
$233.97 - $274.11 $3.9 Million - $4.57 Million
16,682 Added 16.68%
116,679 $29.2 Million
Q4 2017

Feb 06, 2018

BUY
$216.94 - $271.3 $723,494 - $904,785
3,335 Added 3.45%
99,997 $23.9 Million
Q3 2017

Nov 07, 2017

BUY
$212.27 - $242.28 $20.5 Million - $23.4 Million
96,662
96,662 $21.5 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.63B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.